Concepedia

Daniel Wynn

DW

33

Publications

5.2K

Citations

29

H-Index

1990

Active since

Affiliations

Consultants in Neurology(Current)

Cleveland Clinic

University of Illinois Urbana-Champaign

University of Pennsylvania

Heinrich Heine University Düsseldorf

Daniel Wynn is an author at Consultants in Neurology specializing in multiple sclerosis, neurology, and medicine.

ORCID

Top concepts

Publications per year

1990–2022

33

Publications

33

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

Richard A. Rudick, William H. Stuart, Peter A. Calabresi et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

Vittorio Martinelli, M. Rodegher, Lucia Moiola et al. · The Lancet · 2009 · 585 citations

, , +8

Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect

Erik P. Pioro, Benjamin Rix Brooks, Jeffrey L. Cummings et al. · Annals of Neurology · 2010 · 368 citations

The incidence and significance of anti-natalizumab antibodies

Peter A. Calabresi, Gavin Giovannoni, Christian Confavreux et al. · Neurology · 2007 · 329 citations

Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta

Daniel Wynn, Michael D. Kaufman, Xavier Montalbán et al. · The Lancet Neurology · 2010 · 298 citations

, , +10

Rows per page

1–5 of 33